China In Vivo and In Vitro DMPK and ADME Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the In Vivo and In Vitro DMPK and ADME industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pharmaron

    • Lonza

    • Eurofins USA

    • Charles River

    • ICON

    • ChemPartner

    • Joinn Laboratories

    • Tecan Group

    • Aragen Life Sciences

    • Labcorp

    • Envigo

    • Bioduro-Sundia

    • Evotec US Inc

    By Type:

    • Biologics

    • Small Molecules

    By Application:

    • Biopharmaceutical Companies

    • Others

    • Government and Academic Institutes

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China In Vivo and In Vitro DMPK and ADME Market Overview 2018-2029

    • 1.1 China In Vivo and In Vitro DMPK and ADME Industry Development Overview

    • 1.2 China In Vivo and In Vitro DMPK and ADME Industry Development History

    • 1.3 China In Vivo and In Vitro DMPK and ADME Industry Market Size (2018-2029)

    • 1.4 China In Vivo and In Vitro DMPK and ADME Market Analysis by Type from Production Side

      • 1.4.1 China In Vivo and In Vitro DMPK and ADME Production Volume, Production Value and Growth Rate of Biologics (2018-2029)

      • 1.4.2 China In Vivo and In Vitro DMPK and ADME Production Volume, Production Value and Growth Rate of Small Molecules (2018-2029)

    • 1.5 China In Vivo and In Vitro DMPK and ADME Market Analysis by Application from Consumption End

      • 1.5.1 China In Vivo and In Vitro DMPK and ADME Sales Volume, Sales Value and Growth Rate of Biopharmaceutical Companies (2018-2029)

      • 1.5.2 China In Vivo and In Vitro DMPK and ADME Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China In Vivo and In Vitro DMPK and ADME Sales Volume, Sales Value and Growth Rate of Government and Academic Institutes (2018-2029)

    • 1.6 China In Vivo and In Vitro DMPK and ADME Market Analysis by Region

      • 1.6.1 North China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

    Chapter 2 China In Vivo and In Vitro DMPK and ADME Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on In Vivo and In Vitro DMPK and ADME Market Status and Competition at home and abroad in 2023

      • 2.2.2 China In Vivo and In Vitro DMPK and ADME Market Status and Competition Analysis in 2023

      • 2.2.3 China In Vivo and In Vitro DMPK and ADME Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China In Vivo and In Vitro DMPK and ADME Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on In Vivo and In Vitro DMPK and ADME Industry Development

    Chapter 3 In Vivo and In Vitro DMPK and ADMEIndustry Chain Analysis

    • 3.1 In Vivo and In Vitro DMPK and ADME Industry Chain

    • 3.2 In Vivo and In Vitro DMPK and ADME Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the In Vivo and In Vitro DMPK and ADME Market

    • 3.3 In Vivo and In Vitro DMPK and ADME Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the In Vivo and In Vitro DMPK and ADME Market

    Chapter 4 China In Vivo and In Vitro DMPK and ADME Market, by Type

    • 4.1 China In Vivo and In Vitro DMPK and ADME Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China In Vivo and In Vitro DMPK and ADME Total Production Volume and Growth Rate from Production Side

    • 4.5 China In Vivo and In Vitro DMPK and ADME Production Volume and Growth Rate, by Type

      • 4.5.1 China In Vivo and In Vitro DMPK and ADME Production Volume and Growth Rate of Biologics

      • 4.5.2 China In Vivo and In Vitro DMPK and ADME Production Volume and Growth Rate of Small Molecules

    Chapter 5 China In Vivo and In Vitro DMPK and ADME Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China In Vivo and In Vitro DMPK and ADME Total Market Size and Growth Rate from Consumption End

    • 5.5 China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate, by Application

      • 5.5.1 China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate of Biopharmaceutical Companies

      • 5.5.2 China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate of Others

      • 5.5.3 China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate of Government and Academic Institutes

    Chapter 6 China In Vivo and In Vitro DMPK and ADME Market, by Region

    • 6.1 China In Vivo and In Vitro DMPK and ADME Production Volume and Production Value, by Region

    • 6.2 China In Vivo and In Vitro DMPK and ADME Sales Volume and Sales Value, by Region

    Chapter 7 North China In Vivo and In Vitro DMPK and ADME Market Analysis

    • 7.1 North China In Vivo and In Vitro DMPK and ADME Market, by Type

    • 7.2 North China In Vivo and In Vitro DMPK and ADME Market, by Application

    Chapter 8 Central China In Vivo and In Vitro DMPK and ADME Market Analysis

    • 8.1 Central China In Vivo and In Vitro DMPK and ADME Market, by Type

    • 8.2 Central China In Vivo and In Vitro DMPK and ADME Market, by Application

    Chapter 9 South China In Vivo and In Vitro DMPK and ADME Market Analysis

    • 9.1 South China In Vivo and In Vitro DMPK and ADME Market, by Type

    • 9.2 South China In Vivo and In Vitro DMPK and ADME Market, by Application

    Chapter 10 East China In Vivo and In Vitro DMPK and ADME Market Analysis

    • 10.1 East China In Vivo and In Vitro DMPK and ADME Market, by Type

    • 10.2 East China In Vivo and In Vitro DMPK and ADME Market, by Application

    Chapter 11 Northeast China In Vivo and In Vitro DMPK and ADME Market Analysis

    • 11.1 Northeast China In Vivo and In Vitro DMPK and ADME Market, by Type

    • 11.2 Northeast China In Vivo and In Vitro DMPK and ADME Market, by Application

    Chapter 12 Southwest China In Vivo and In Vitro DMPK and ADME Market Analysis

    • 12.1 Southwest China In Vivo and In Vitro DMPK and ADME Market, by Type

    • 12.2 Southwest China In Vivo and In Vitro DMPK and ADME Market, by Application

    Chapter 13 Northwest China In Vivo and In Vitro DMPK and ADME Market Analysis

    • 13.1 Northwest China In Vivo and In Vitro DMPK and ADME Market, by Type

    • 13.2 Northwest China In Vivo and In Vitro DMPK and ADME Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pharmaron

        • 14.1.1 Pharmaron Company Profile

        • 14.1.2 Pharmaron In Vivo and In Vitro DMPK and ADME Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Lonza

        • 14.2.1 Lonza Company Profile

        • 14.2.2 Lonza In Vivo and In Vitro DMPK and ADME Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Eurofins USA

        • 14.3.1 Eurofins USA Company Profile

        • 14.3.2 Eurofins USA In Vivo and In Vitro DMPK and ADME Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Charles River

        • 14.4.1 Charles River Company Profile

        • 14.4.2 Charles River In Vivo and In Vitro DMPK and ADME Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 ICON

        • 14.5.1 ICON Company Profile

        • 14.5.2 ICON In Vivo and In Vitro DMPK and ADME Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 ChemPartner

        • 14.6.1 ChemPartner Company Profile

        • 14.6.2 ChemPartner In Vivo and In Vitro DMPK and ADME Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Joinn Laboratories

        • 14.7.1 Joinn Laboratories Company Profile

        • 14.7.2 Joinn Laboratories In Vivo and In Vitro DMPK and ADME Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Tecan Group

        • 14.8.1 Tecan Group Company Profile

        • 14.8.2 Tecan Group In Vivo and In Vitro DMPK and ADME Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Aragen Life Sciences

        • 14.9.1 Aragen Life Sciences Company Profile

        • 14.9.2 Aragen Life Sciences In Vivo and In Vitro DMPK and ADME Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Labcorp

        • 14.10.1 Labcorp Company Profile

        • 14.10.2 Labcorp In Vivo and In Vitro DMPK and ADME Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Envigo

        • 14.11.1 Envigo Company Profile

        • 14.11.2 Envigo In Vivo and In Vitro DMPK and ADME Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Bioduro-Sundia

        • 14.12.1 Bioduro-Sundia Company Profile

        • 14.12.2 Bioduro-Sundia In Vivo and In Vitro DMPK and ADME Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Evotec US Inc

        • 14.13.1 Evotec US Inc Company Profile

        • 14.13.2 Evotec US Inc In Vivo and In Vitro DMPK and ADME Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 In Vivo and In Vitro DMPK and ADME Industry Research Conclusions

    • 15.2 In Vivo and In Vitro DMPK and ADME Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China In Vivo and In Vitro DMPK and ADME Industry Market Size (2018-2029)

    • Figure China In Vivo and In Vitro DMPK and ADME Production Volume, Production Value and Growth Rate of Biologics (2018-2029)

    • Figure China In Vivo and In Vitro DMPK and ADME Production Volume, Production Value and Growth Rate of Small Molecules (2018-2029)

    • Figure China In Vivo and In Vitro DMPK and ADME Sales Volume, Sales Value and Growth Rate of Biopharmaceutical Companies (2018-2029)

    • Figure China In Vivo and In Vitro DMPK and ADME Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China In Vivo and In Vitro DMPK and ADME Sales Volume, Sales Value and Growth Rate of Government and Academic Institutes (2018-2029)

    • Figure North China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

    • Figure Central China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

    • Figure South China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

    • Figure East China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

    • Figure Northeast China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

    • Figure Southwest China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

    • Figure Northwest China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate from 2018-2029

    • Figure In Vivo and In Vitro DMPK and ADME Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China In Vivo and In Vitro DMPK and ADME Market Share by Type in 2018

    • Figure China In Vivo and In Vitro DMPK and ADME Market Share by Type in 2023

    • Figure China In Vivo and In Vitro DMPK and ADME Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China In Vivo and In Vitro DMPK and ADME Production Volume and Growth Rate of Biologics (2018-2023)

    • Figure China In Vivo and In Vitro DMPK and ADME Production Volume and Growth Rate of Small Molecules (2018-2023)

    • Figure China In Vivo and In Vitro DMPK and ADME Market Share by Application in 2018

    • Figure China In Vivo and In Vitro DMPK and ADME Market Share by Application in 2023

    • Figure China In Vivo and In Vitro DMPK and ADME Total Market Size and Growth Rate from Consumption End

    • Figure China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate of Biopharmaceutical Companies (2018-2023)

    • Figure China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate of Others (2018-2023)

    • Figure China In Vivo and In Vitro DMPK and ADME Market Size and Growth Rate of Government and Academic Institutes (2018-2023)

    • Table China In Vivo and In Vitro DMPK and ADME Production Volume by Region (2018-2023)

    • Table China In Vivo and In Vitro DMPK and ADME Production Volume Share by Region (2018-2023)

    • Figure China In Vivo and In Vitro DMPK and ADME Production Volume Share by Region (2018-2023)

    • Table China In Vivo and In Vitro DMPK and ADME Production Value by Region (2018-2023)

    • Table China In Vivo and In Vitro DMPK and ADME Production Value Share by Region (2018-2023)

    • Figure China In Vivo and In Vitro DMPK and ADME Production Value Share by Region (2018-2023)

    • Table China In Vivo and In Vitro DMPK and ADME Sales Volume by Region (2018-2023)

    • Table China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Region (2018-2023)

    • Figure China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Region (2018-2023)

    • Table China In Vivo and In Vitro DMPK and ADME Sales Value by Region (2018-2023)

    • Table China In Vivo and In Vitro DMPK and ADME Sales Value Share by Region (2018-2023)

    • Figure China In Vivo and In Vitro DMPK and ADME Sales Value Share by Region (2018-2023)

    • Table North China In Vivo and In Vitro DMPK and ADME Production Volume by Type (2018-2023)

    • Table North China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Figure North China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Table North China In Vivo and In Vitro DMPK and ADME Sales Volume by Application (2018-2023)

    • Table North China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Figure North China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Table Central China In Vivo and In Vitro DMPK and ADME Production Volume by Type (2018-2023)

    • Table Central China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Figure Central China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Table Central China In Vivo and In Vitro DMPK and ADME Sales Volume by Application (2018-2023)

    • Table Central China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Figure Central China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Table South China In Vivo and In Vitro DMPK and ADME Production Volume by Type (2018-2023)

    • Table South China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Figure South China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Table South China In Vivo and In Vitro DMPK and ADME Sales Volume by Application (2018-2023)

    • Table South China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Figure South China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Table East China In Vivo and In Vitro DMPK and ADME Production Volume by Type (2018-2023)

    • Table East China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Figure East China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Table East China In Vivo and In Vitro DMPK and ADME Sales Volume by Application (2018-2023)

    • Table East China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Figure East China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Table Northeast China In Vivo and In Vitro DMPK and ADME Production Volume by Type (2018-2023)

    • Table Northeast China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Figure Northeast China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Table Northeast China In Vivo and In Vitro DMPK and ADME Sales Volume by Application (2018-2023)

    • Table Northeast China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Figure Northeast China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Table Southwest China In Vivo and In Vitro DMPK and ADME Production Volume by Type (2018-2023)

    • Table Southwest China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Figure Southwest China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Table Southwest China In Vivo and In Vitro DMPK and ADME Sales Volume by Application (2018-2023)

    • Table Southwest China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Figure Southwest China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Table Northwest China In Vivo and In Vitro DMPK and ADME Production Volume by Type (2018-2023)

    • Table Northwest China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Figure Northwest China In Vivo and In Vitro DMPK and ADME Production Volume Share by Type (2018-2023)

    • Table Northwest China In Vivo and In Vitro DMPK and ADME Sales Volume by Application (2018-2023)

    • Table Northwest China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Figure Northwest China In Vivo and In Vitro DMPK and ADME Sales Volume Share by Application (2018-2023)

    • Table Pharmaron Company Profile

    • Table Pharmaron In Vivo and In Vitro DMPK and ADME Revenue, Price and Gross (2018-2023)

    • Table Lonza Company Profile

    • Table Lonza In Vivo and In Vitro DMPK and ADME Revenue, Price and Gross (2018-2023)

    • Table Eurofins USA Company Profile

    • Table Eurofins USA In Vivo and In Vitro DMPK and ADME Revenue, Price and Gross (2018-2023)

    • Table Charles River Company Profile

    • Table Charles River In Vivo and In Vitro DMPK and ADME Revenue, Price and Gross (2018-2023)

    • Table ICON Company Profile

    • Table ICON In Vivo and In Vitro DMPK and ADME Revenue, Price and Gross (2018-2023)

    • Table ChemPartner Company Profile

    • Table ChemPartner In Vivo and In Vitro DMPK and ADME Revenue, Price and Gross (2018-2023)

    • Table Joinn Laboratories Company Profile

    • Table Joinn Laboratories In Vivo and In Vitro DMPK and ADME Revenue, Price and Gross (2018-2023)

    • Table Tecan Group Company Profile

    • Table Tecan Group In Vivo and In Vitro DMPK and ADME Revenue, Price and Gross (2018-2023)

    • Table Aragen Life Sciences Company Profile

    • Table Aragen Life Sciences In Vivo and In Vitro DMPK and ADME Revenue, Price and Gross (2018-2023)

    • Table Labcorp Company Profile

    • Table Labcorp In Vivo and In Vitro DMPK and ADME Revenue, Price and Gross (2018-2023)

    • Table Envigo Company Profile

    • Table Envigo In Vivo and In Vitro DMPK and ADME Revenue, Price and Gross (2018-2023)

    • Table Bioduro-Sundia Company Profile

    • Table Bioduro-Sundia In Vivo and In Vitro DMPK and ADME Revenue, Price and Gross (2018-2023)

    • Table Evotec US Inc Company Profile

    • Table Evotec US Inc In Vivo and In Vitro DMPK and ADME Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.